CA 15-3 and related mucins as circulating markers in breast cancer.
about
Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library.Analysis of Isocitrate Dehydrogenase -2 (IDH-2) Activity in Human Serum as a Biomarker in Chemotherapy Patients of Breast Carcinoma: A Case-Control Study.Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.Circulating microRNAs as specific biomarkers for breast cancer detection.Protein biomarkers for the early detection of breast cancer.The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers.Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkersOccult breast cancer presenting as metastatic adenocarcinoma of unknown primary: clinical presentation, immunohistochemistry, and molecular analysisCorrelation study of Carcino Embryonic Antigen & Cancer Antigen 15.3 in pretreated female breast cancer patientsProfiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies.Electroanalytical and surface plasmon resonance sensors for detection of breast cancer and Alzheimer's disease biomarkers in cells and body fluids.MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells.Early Diagnosis of Breast CancerPankoMab: a potent new generation anti-tumour MUC1 antibody.Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells.The clinical significance of serum soluble Fas and p53 protein in breast cancer patients: comparison with serum CA 15-3.Implications of different CA 15-3 levels according to breast cancer subtype at initial diagnosis of recurrent or metastatic breast cancer.Biomarker Studies in Early Detection and Prognosis of Breast Cancer.Prognostic role of CA15.3 in 7942 patients with operable breast cancer.Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?
P2860
Q33184085-D74B5D44-7A8D-4A39-AFBD-DEE3561B8FD3Q33831823-11E79751-5CE1-433B-8E1E-40346BB62958Q34347517-C296B314-EB23-4627-A659-F192671B6169Q34542335-CD24DF0C-5076-4CFF-A71A-9A2D74D4CD84Q35367572-B8C2C7CC-1F17-4A04-B048-C9CF2728228DQ35482100-7E4FBACE-982C-4E20-A04A-E6C1DA7E9B53Q35752096-B511EE70-A133-42EA-9784-1E0B58D41CF3Q35789437-DB974220-8FC3-4ABD-A481-6FE7F07728BEQ36266095-1811EC32-BC45-4AE8-AB10-67BE01969EAAQ37341286-3A56244C-4EE0-43E9-B1DE-364EC8E0ED5BQ38193833-7C8DE741-57CE-4862-AC3D-6645A9F49B6CQ39064248-E31D3DD5-C261-4BD2-9AB5-39185B7E1F49Q39415180-F1E556DF-6178-4ECA-912A-A9C7E0A3A599Q40314964-A11201A1-5615-48E7-9130-36128D75919FQ40606989-22991FE0-1046-441F-A659-92A0C02C2D6DQ46842347-E55A2E38-26BD-4ECB-9088-C87B94DE853DQ48000299-416086AC-65FD-4BD2-97EC-FFA2F1FE416FQ49544412-C8481513-A68B-43F7-A9DA-17055880C84FQ50995298-9F86F85F-5D86-46FB-877B-1F1FDF3C30D7Q54474404-F0DE5278-D65C-4972-924A-BDF9AB59DA60Q55447627-CF24124B-DC1A-4C31-9D28-1FBA32F811F9
P2860
CA 15-3 and related mucins as circulating markers in breast cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
CA 15-3 and related mucins as circulating markers in breast cancer.
@ast
CA 15-3 and related mucins as circulating markers in breast cancer.
@en
type
label
CA 15-3 and related mucins as circulating markers in breast cancer.
@ast
CA 15-3 and related mucins as circulating markers in breast cancer.
@en
prefLabel
CA 15-3 and related mucins as circulating markers in breast cancer.
@ast
CA 15-3 and related mucins as circulating markers in breast cancer.
@en
P1476
CA 15-3 and related mucins as circulating markers in breast cancer.
@en
P2093
P304
P356
10.1177/000456329903600503
P478
36 ( Pt 5)
P577
1999-09-01T00:00:00Z